Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Preaxia Health Care Payment Systems (PAXH) Cash & Equivalents (2019 - 2025)

Preaxia Health Care Payment Systems' Cash & Equivalents history spans 7 years, with the latest figure at $130285.0 for Q3 2025.

  • For Q3 2025, Cash & Equivalents rose 13028400.0% year-over-year to $130285.0; the TTM value through Aug 2025 reached $130285.0, up 13028400.0%, while the annual FY2024 figure was $14.0, 133.33% up from the prior year.
  • Cash & Equivalents for Q3 2025 was $130285.0 at Preaxia Health Care Payment Systems, up from $3.0 in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $130285.0 in Q3 2025 and bottomed at $1.0 in Q3 2024.
  • The 5-year median for Cash & Equivalents is $165.0 (2024), against an average of $7943.8.
  • The largest YoY upside for Cash & Equivalents was 13028400.0% in 2025 against a maximum downside of 99.75% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $110.0 in 2021, then skyrocketed by 59.09% to $175.0 in 2022, then skyrocketed by 967.43% to $1868.0 in 2023, then plummeted by 91.17% to $165.0 in 2024, then soared by 78860.61% to $130285.0 in 2025.
  • Per Business Quant, the three most recent readings for PAXH's Cash & Equivalents are $130285.0 (Q3 2025), $3.0 (Q1 2025), and $165.0 (Q4 2024).